-
Vectura Limited v. GlaxoSmithKline LLC et al DC CAFC
- 1:16-cv-00638
- D. Del.
- Judge: Richard G. Andrews
- Filed: 07/27/2016
- Closed: 05/16/2019
- Latest Docket Entry: 03/09/2021
- PACER
- Docket updated daily
1
Plaintiff
2
Defendants
4
Accused
Products
3
Patents-in-Suit
1,024
Days in
Litigation
-
Vectura Limited v. GlaxoSmithKline LLC et al DC CAFC
- 1:16-cv-00638
- D. Del.
- Judge: Richard G. Andrews
- Filed: 07/27/2016
- Closed: 05/16/2019
- Latest Docket Entry: 03/09/2021
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim | Outcome |
---|---|
All challenged claims |
Valid
Entry 255 |
-
Infringement
Glaxo Group Limited
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Anoro ElliptaBreo Ellipta 100/25Breo Ellipta 200/25Incruse Ellipta | US 8,303,991 B2 |
3
|
Willful infringement
Entry 366
|
GlaxoSmithKline LLC
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Anoro ElliptaBreo Ellipta 100/25Breo Ellipta 200/25Incruse Ellipta | US 8,303,991 B2 |
3
|
Willful infringement
Entry 366Entry 322 |
-
Damages